2-[(1R,3S)-3-[[(4R)-2-amino-1-methyl-5-oxo-4-(2-phenylethyl)imidazol-4-yl]methyl]cyclohexyl]-N-naphthalen-2-ylacetamide;3,5-dimethyl-5-[3-[3-(trifluoromethoxy)phenyl]phenyl]-4H-imidazol-2-amine;5-[3-(6-methoxy-3-pyridinyl)phenyl]-3,5-dimethyl-4H-imidazol-2-amine

C66H74F3N11O4 — CID 159520378

IUPAC2-[(1R,3S)-3-[[(4R)-2-amino-1-methyl-5-oxo-4-(2-phenylethyl)imidazol-4-yl]methyl]cyclohexyl]-N-naphthalen-2-ylacetamide;3,5-dimethyl-5-[3-[3-(trifluoromethoxy)phenyl]phenyl]-4H-imidazol-2-amine;5-[3-(6-methoxy-3-pyridinyl)phenyl]-3,5-dimethyl-4H-imidazol-2-amine
SMILESCN1C(=O)[C@@](CCc2ccccc2)(C[C@H]2CCC[C@@H](CC(=O)Nc3ccc4ccccc4c3)C2)N=C1N.CN1CC(C)(c2cccc(-c3cccc(OC(F)(F)F)c3)c2)N=C1N.COc1ccc(-c2cccc(C3(C)CN(C)C(N)=N3)c2)cn1
InChIInChI=1S/C31H36N4O2.C18H18F3N3O.C17H20N4O/c1-35-29(37)31(34-30(35)32,17-16-22-8-3-2-4-9-22)21-24-11-7-10-23(18-24)19-28(36)33-27-15-14-25-12-5-6-13-26(25)20-27;1-17(11-24(2)16(22)23-17)14-7-3-5-12(9-14)13-6-4-8-15(10-13)25-18(19,20)21;1-17(11-21(2)16(18)20-17)14-6-4-5-12(9-14)13-7-8-15(22-3)19-10-13/h2-6,8-9,12-15,20,23-24H,7,10-11,16-19,21H2,1H3,(H2,32,34)(H,33,36);3-10H,11H2,1-2H3,(H2,22,23);4-10H,11H2,1-3H3,(H2,18,20)/t23-,24+,31-;;/m1../s1
InChIKeyMBSLXXOCHGUIAJ-KEKRLGDISA-N
MW1142.38 g/mol
LogP11.48
Rot. Bonds14

About 2-[(1R,3S)-3-[[(4R)-2-amino-1-methyl-5-oxo-4-(2-phenylethyl)imidazol-4-yl]methyl]cyclohexyl]-N-naphthalen-2-ylacetamide;3,5-dimethyl-5-[3-[3-(trifluoromethoxy)phenyl]phenyl]-4H-imidazol-2-amine;5-[3-(6-methoxy-3-pyridinyl)phenyl]-3,5-dimethyl-4H-imidazol-2-amine

2-[(1R,3S)-3-[[(4R)-2-amino-1-methyl-5-oxo-4-(2-phenylethyl)imidazol-4-yl]methyl]cyclohexyl]-N-naphthalen-2-ylacetamide;3,5-dimethyl-5-[3-[3-(trifluoromethoxy)phenyl]phenyl]-4H-imidazol-2-amine;5-[3-(6-methoxy-3-pyridinyl)phenyl]-3,5-dimethyl-4H-imidazol-2-amine (PubChem CID 159520378) has the molecular formula C66H74F3N11O4 and a molecular weight of 1142.38 g/mol. Its IUPAC name is 2-[(1R,3S)-3-[[(4R)-2-amino-1-methyl-5-oxo-4-(2-phenylethyl)imidazol-4-yl]methyl]cyclohexyl]-N-naphthalen-2-ylacetamide;3,5-dimethyl-5-[3-[3-(trifluoromethoxy)phenyl]phenyl]-4H-imidazol-2-amine;5-[3-(6-methoxy-3-pyridinyl)phenyl]-3,5-dimethyl-4H-imidazol-2-amine.

Molecular Properties

Compound Name2-[(1R,3S)-3-[[(4R)-2-amino-1-methyl-5-oxo-4-(2-phenylethyl)imidazol-4-yl]methyl]cyclohexyl]-N-naphthalen-2-ylacetamide;3,5-dimethyl-5-[3-[3-(trifluoromethoxy)phenyl]phenyl]-4H-imidazol-2-amine;5-[3-(6-methoxy-3-pyridinyl)phenyl]-3,5-dimethyl-4H-imidazol-2-amine
PubChem CID159520378
Molecular FormulaC66H74F3N11O4
Molecular Weight1142.38 g/mol
Exact Mass1141.59
IUPAC Name2-[(1R,3S)-3-[[(4R)-2-amino-1-methyl-5-oxo-4-(2-phenylethyl)imidazol-4-yl]methyl]cyclohexyl]-N-naphthalen-2-ylacetamide;3,5-dimethyl-5-[3-[3-(trifluoromethoxy)phenyl]phenyl]-4H-imidazol-2-amine;5-[3-(6-methoxy-3-pyridinyl)phenyl]-3,5-dimethyl-4H-imidazol-2-amine
SMILESCN1C(=O)[C@@](CCc2ccccc2)(C[C@H]2CCC[C@@H](CC(=O)Nc3ccc4ccccc4c3)C2)N=C1N.CN1CC(C)(c2cccc(-c3cccc(OC(F)(F)F)c3)c2)N=C1N.COc1ccc(-c2cccc(C3(C)CN(C)C(N)=N3)c2)cn1
InChIInChI=1S/C31H36N4O2.C18H18F3N3O.C17H20N4O/c1-35-29(37)31(34-30(35)32,17-16-22-8-3-2-4-9-22)21-24-11-7-10-23(18-24)19-28(36)33-27-15-14-25-12-5-6-13-26(25)20-27;1-17(11-24(2)16(22)23-17)14-7-3-5-12(9-14)13-6-4-8-15(10-13)25-18(19,20)21;1-17(11-21(2)16(18)20-17)14-6-4-5-12(9-14)13-7-8-15(22-3)19-10-13/h2-6,8-9,12-15,20,23-24H,7,10-11,16-19,21H2,1H3,(H2,32,34)(H,33,36);3-10H,11H2,1-2H3,(H2,22,23);4-10H,11H2,1-3H3,(H2,18,20)/t23-,24+,31-;;/m1../s1
InChIKeyMBSLXXOCHGUIAJ-KEKRLGDISA-N
XLogP11.48
TPSA202.38 Ų
H-Bond Donors4
H-Bond Acceptors13
Rotatable Bonds14
Heavy Atoms84
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001142.38
LogP ≤ 511.48
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1013

Analyze 2-[(1R,3S)-3-[[(4R)-2-amino-1-methyl-5-oxo-4-(2-phenylethyl)imidazol-4-yl]methyl]cyclohexyl]-N-naphthalen-2-ylacetamide;3,5-dimethyl-5-[3-[3-(trifluoromethoxy)phenyl]phenyl]-4H-imidazol-2-amine;5-[3-(6-methoxy-3-pyridinyl)phenyl]-3,5-dimethyl-4H-imidazol-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[(1R,3S)-3-[[(4R)-2-amino-1-methyl-5-oxo-4-(2-phenylethyl)imidazol-4-yl]methyl]cyclohexyl]-N-naphthalen-2-ylacetamide;3,5-dimethyl-5-[3-[3-(trifluoromethoxy)phenyl]phenyl]-4H-imidazol-2-amine;5-[3-(6-methoxy-3-pyridinyl)phenyl]-3,5-dimethyl-4H-imidazol-2-amine?
The IUPAC name of 2-[(1R,3S)-3-[[(4R)-2-amino-1-methyl-5-oxo-4-(2-phenylethyl)imidazol-4-yl]methyl]cyclohexyl]-N-naphthalen-2-ylacetamide;3,5-dimethyl-5-[3-[3-(trifluoromethoxy)phenyl]phenyl]-4H-imidazol-2-amine;5-[3-(6-methoxy-3-pyridinyl)phenyl]-3,5-dimethyl-4H-imidazol-2-amine (CID 159520378) is 2-[(1R,3S)-3-[[(4R)-2-amino-1-methyl-5-oxo-4-(2-phenylethyl)imidazol-4-yl]methyl]cyclohexyl]-N-naphthalen-2-ylacetamide;3,5-dimethyl-5-[3-[3-(trifluoromethoxy)phenyl]phenyl]-4H-imidazol-2-amine;5-[3-(6-methoxy-3-pyridinyl)phenyl]-3,5-dimethyl-4H-imidazol-2-amine.
What is the SMILES notation for 2-[(1R,3S)-3-[[(4R)-2-amino-1-methyl-5-oxo-4-(2-phenylethyl)imidazol-4-yl]methyl]cyclohexyl]-N-naphthalen-2-ylacetamide;3,5-dimethyl-5-[3-[3-(trifluoromethoxy)phenyl]phenyl]-4H-imidazol-2-amine;5-[3-(6-methoxy-3-pyridinyl)phenyl]-3,5-dimethyl-4H-imidazol-2-amine?
The canonical SMILES for 2-[(1R,3S)-3-[[(4R)-2-amino-1-methyl-5-oxo-4-(2-phenylethyl)imidazol-4-yl]methyl]cyclohexyl]-N-naphthalen-2-ylacetamide;3,5-dimethyl-5-[3-[3-(trifluoromethoxy)phenyl]phenyl]-4H-imidazol-2-amine;5-[3-(6-methoxy-3-pyridinyl)phenyl]-3,5-dimethyl-4H-imidazol-2-amine is CN1C(=O)[C@@](CCc2ccccc2)(C[C@H]2CCC[C@@H](CC(=O)Nc3ccc4ccccc4c3)C2)N=C1N.CN1CC(C)(c2cccc(-c3cccc(OC(F)(F)F)c3)c2)N=C1N.COc1ccc(-c2cccc(C3(C)CN(C)C(N)=N3)c2)cn1.
What is the InChIKey of 2-[(1R,3S)-3-[[(4R)-2-amino-1-methyl-5-oxo-4-(2-phenylethyl)imidazol-4-yl]methyl]cyclohexyl]-N-naphthalen-2-ylacetamide;3,5-dimethyl-5-[3-[3-(trifluoromethoxy)phenyl]phenyl]-4H-imidazol-2-amine;5-[3-(6-methoxy-3-pyridinyl)phenyl]-3,5-dimethyl-4H-imidazol-2-amine?
The InChIKey is MBSLXXOCHGUIAJ-KEKRLGDISA-N. The full InChI is InChI=1S/C31H36N4O2.C18H18F3N3O.C17H20N4O/c1-35-29(37)31(34-30(35)32,17-16-22-8-3-2-4-9-22)21-24-11-7-10-23(18-24)19-28(36)33-27-15-14-25-12-5-6-13-26(25)20-27;1-17(11-24(2)16(22)23-17)14-7-3-5-12(9-14)13-6-4-8-15(10-13)25-18(19,20)21;1-17(11-21(2)16(18)20-17)14-6-4-5-12(9-14)13-7-8-15(22-3)19-10-13/h2-6,8-9,12-15,20,23-24H,7,10-11,16-19,21H2,1H3,(H2,32,34)(H,33,36);3-10H,11H2,1-2H3,(H2,22,23);4-10H,11H2,1-3H3,(H2,18,20)/t23-,24+,31-;;/m1../s1.
What are the key properties of 2-[(1R,3S)-3-[[(4R)-2-amino-1-methyl-5-oxo-4-(2-phenylethyl)imidazol-4-yl]methyl]cyclohexyl]-N-naphthalen-2-ylacetamide;3,5-dimethyl-5-[3-[3-(trifluoromethoxy)phenyl]phenyl]-4H-imidazol-2-amine;5-[3-(6-methoxy-3-pyridinyl)phenyl]-3,5-dimethyl-4H-imidazol-2-amine?
2-[(1R,3S)-3-[[(4R)-2-amino-1-methyl-5-oxo-4-(2-phenylethyl)imidazol-4-yl]methyl]cyclohexyl]-N-naphthalen-2-ylacetamide;3,5-dimethyl-5-[3-[3-(trifluoromethoxy)phenyl]phenyl]-4H-imidazol-2-amine;5-[3-(6-methoxy-3-pyridinyl)phenyl]-3,5-dimethyl-4H-imidazol-2-amine has a molecular weight of 1142.38 g/mol, XLogP of 11.48, 14 rotatable bonds, 4 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(1R,3S)-3-[[(4R)-2-amino-1-methyl-5-oxo-4-(2-phenylethyl)imidazol-4-yl]methyl]cyclohexyl]-N-naphthalen-2-ylacetamide;3,5-dimethyl-5-[3-[3-(trifluoromethoxy)phenyl]phenyl]-4H-imidazol-2-amine;5-[3-(6-methoxy-3-pyridinyl)phenyl]-3,5-dimethyl-4H-imidazol-2-amine is sourced from PubChem (CID 159520378), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).